Incidence of Infections and Second Cancers in Philadelphia Chromosome-Negative Patients with Myeloproliferative Neoplasms Treated with Ruxolitinib

被引：0
|
作者：
Ritchie, Ellen K.
Krichevsky, Spencer
Roboz, Gail J.
Silver, Richard T.
Schafer, Andrew I.
Scandura, Joseph
Desai, Pinkal
Samuel, Sangmin Leeand Michael
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2910
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Impact of Bone Marrow Pathology on the Clinical Management of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
    Pozdnyakova, Olga
    Hasserjian, Robert P.
    Verstovsek, Srdan
    Orazi, Attilio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (05): : 253 - 261
  • [22] Philadelphia chromosome-negative myeloproliferative disorders: Biology and treatment
    Hoffman, Ronald
    Prchal, Josef T.
    Samuelson, Scott
    Ciurea, Stefan O.
    Rondelli, Damiano
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (01) : 64 - 72
  • [23] Pegylated interferon therapy for patients with Philadelphia chromosome-negative myeloproliferative disorders
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop M.
    Giles, Francis
    Verstovsek, Srdan
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (04): : 409 - 416
  • [24] Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders
    Kuznetsova, Polina I.
    Raskurazhev, Anton A.
    Konovalov, Rodion N.
    Krotenkova, Marina V.
    Chechetkin, Andrey O.
    Lagoda, Olga V.
    Melikhyan, Anait L.
    Tanashyan, Marine M.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [25] The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms
    Zhiyuan Wu
    Xinju Zhang
    Xiao Xu
    Yuming Chen
    Tingting Hu
    Zhihua Kang
    Shibao Li
    Hua Wang
    Weiwei Liu
    Xiaochao Ma
    Ming Guan
    Journal of Hematology & Oncology, 7
  • [26] Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms
    Boddu, Prajwal
    Masarova, Lucia
    Verstovsek, Srdan
    Strati, Paolo
    Kantarjian, Hagop
    Cortes, Jorge
    Estrov, Zeev
    Pierce, Sherry
    Pemmaraju, Naveen
    ANNALS OF HEMATOLOGY, 2018, 97 (01) : 109 - 121
  • [27] Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
    Barbuil, Tiziano
    Tefferi, Ayalew
    Vannucchi, Alessandro M.
    Passamonti, Francesco
    Silvers, Richard T.
    Hoffman, Ronald
    Verstovsek, Srdan
    Mesa, Ruben
    Kiladjian, Jean-Jacques
    Hehlmann, Rudiger
    Reiter, Andreas
    Cervantes, Francisco
    Harrison, Claire
    Mc Mullin, Mary Frances
    Hasselbalch, Hans Carl
    Koschmieder, Steffen
    Marchetti, Monia
    Bacigalupo, Andrea
    Finazzil, Guido
    Kroeger, Nicolaus
    Griesshammer, Martin
    Birgegard, Gunnar
    Barosi, Giovanni
    LEUKEMIA, 2018, 32 (05) : 1057 - 1069
  • [28] The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms
    Wu, Zhiyuan
    Zhang, Xinju
    Xu, Xiao
    Chen, Yuming
    Hu, Tingting
    Kang, Zhihua
    Li, Shibao
    Wang, Hua
    Liu, Weiwei
    Ma, Xiaochao
    Guan, Ming
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [29] Cooperation between pathologists and clinicians allows a better diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms
    Gianelli, Umberto
    Iurlo, Alessandra
    Cattaneo, Daniele
    Lambertenghi-Deliliers, Giorgio
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (02) : 255 - 264
  • [30] Effect of Charlson comorbidity index on vascular events and survival in Philadelphia chromosome-negative myeloproliferative neoplasms
    Ahmed, Shimaa A.
    Aly, Mai M.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2021, 46 (02): : 111 - 115
12345